Hepatocellular organellar abnormalities following elimination of hepatitis C virus

H Aoyagi, H Iijima, ES Gaber, T Zaitsu… - Liver …, 2023 - Wiley Online Library
Background and aims The future development of hepatocellular carcinoma (HCC) in
patients after sustained virologic response (SVR) is an important issue. The purposes of this …

[HTML][HTML] Clinical advances in fibrosis progression of chronic hepatitis B and C

YJ Wu, MY Xu, LG Lu - Journal of Clinical and Translational …, 2014 - ncbi.nlm.nih.gov
Chronic liver diseases, such as chronic hepatitis B (CHB) and chronic hepatitis C (CHC), are
characterized by the presence of liver fibrosis, which may ultimately lead to cirrhosis. The …

Impact of clinical and sociodemographic factors on fatigue among patients with substance use disorder: a cohort study from Norway for the period 2016–2020

JH Vold, R Gjestad, CF Aas, F Chalabianloo… - … , Prevention, and Policy, 2020 - Springer
Background The impact of clinical and sociodemographic factors on fatigue remains
unknown among patients with substance use disorders (SUD). This study aims to evaluate …

Activated Hepatic Stellate Cells (Ito Cells)-Marker of Advanced Fibrosis in Chronic Viral Hepatitis C: A Pilot Study.

RT Sufleţel, C Stanca Melincovici… - … of Gastrointestinal & …, 2023 - search.ebscohost.com
Abstract Background & Aims: The aim of this study is to determine whether activated
hepatic stellate cells (HSCs) may represent a prognostic marker of progressive liver fibrosis …

Contribution of genes for killer cell immunoglobulin-like receptors (KIR) to the susceptibility to chronic hepatitis C virus infection and to viremia

P Kuśnierczyk, I Mozer-Lisewska, K Zwolińska… - Human immunology, 2015 - Elsevier
Background Natural killer (NK) cells are an important element of innate immunity against
viruses, although their numbers decrease in the liver during chronic HCV infection. NK cells …

Effects of HCV Clearance with Direct-Acting Antivirals (DAAs) on Liver Stiffness, Liver Fibrosis Stage and Metabolic/Cellular Parameters

J Ferreira, M Bicho, F Serejo - Viruses, 2024 - mdpi.com
Introduction: Chronic hepatitis C (CHC) is a clinical and pathological syndrome with various
causes and is characterized by varying degrees of hepatocellular necrosis and …

Efficacy and safety of direct‐acting antiviral therapies and baseline predictors for treatment outcomes in hepatitis C patients: A multicenter, real‐world study in …

Z Xie, K Deng, Y Xia, C Zhang, M Xu… - Journal of Medical …, 2022 - Wiley Online Library
The data on direct‐acting antivirals (DAAs) in chronic hepatitis C (CHC) patients in southern
China with multiple genotypes circulating are limited. This study aims to evaluate the efficacy …

真实世界中不同ALT, AST 水平慢性丙型肝炎患者对直接抗病毒药物治疗的病毒学应答及肝纤维化指标变化情况

陈宏宇, 亢倩, 罗皓, 谭宁, 潘家莉, 程然, 韩一凡… - 临床肝胆病杂志, 2021 - lcgdbzz.org
目的探讨真实世界中不同ALT, AST 水平的慢性丙型肝炎患者对直接抗病毒药物(DAA)
治疗的病毒学应答, 以及治疗后肝硬度测定(LSM) 值, 4 项因素的肝纤维化指数(FIB-4) …

The relationship between the serum RNA titers of hepatitis C virus and biochemical parameters in chronic hepatitis C patients

R Nar, F Milletli Sezgin - 2016 - openaccess.ahievran.edu.tr
Objective: Liver biopsy, as well as some non-invasive biochemical parameters are also used
in monitoring patients with chronic hepatitis C (CHC). The aim of this study was to …

RETRACTED ARTICLE: The diagnostic nomogram of platelet-based score models for hepatic alveolar echinococcosis and atypical liver cancer

Q Du, Y Wang, S Guan, C Hu, M Li, L Zhou, M Zhang… - Scientific Reports, 2019 - nature.com
Hepatic alveolar echinococcosis (HAE) and liver cancer had similarities in imaging results,
clinical characteristics, and so on. And it is difficult for clinicians to distinguish them before …